Načítá se...

Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012

Hepatocellular carcinoma (HCC) remains a major global health problem and Calabria in the south of Italy is not an exception. Sorafenib is the first and only Food and Drug Administration approved drug for the treatment of advanced HCC and it is currently under intensive monitoring by the Health Autho...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cilurzo, Felisa, Staltari, Orietta, Patanè, Marinella, Ammendola, Michele, Garaffo, Caterina, Di Paola, Eugenio Donato
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853677/
https://ncbi.nlm.nih.gov/pubmed/24347990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.120971
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!